Key result
Metabolic stress exacerbates calcium dysregulation and severe arrhythmias in preclinical CPVT.
Why the study?
CPVT hearts are typically anatomically normal and lack pathological remodelling, but the impact of additional stressors such as metabolic stress on arrhythmias and cardiac dysfunction was unclear.
Does metabolic stress exacerbate Ca2+ dysregulation and arrhythmias in a murine model of catecholaminergic polymorphic ventricular tachycardia (CPVT)?
Does metabolic stress exacerbate Ca2+ dysregulation and arrhythmias in a murine model of catecholaminergic polymorphic ventricular tachycardia (CPVT)?
p-value: p=<0.05
Metabolic stress exacerbates underlying RyR2 leak and Ca2+ dysregulation in CPVT, leading to more severe arrhythmias, diastolic dysfunction, and hypertrophy.
Metabolic stress may aggravate CPVT in diabetic mice; leaves open human relevance and requires prospective validation.
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a genetic arrhythmic syndrome caused by mutations in the sarcoplasmic reticulum (SR) calcium (Ca 2+ ) release channel RyR2 or its accessory proteins, including calsequestrin‐2 (CASQ2). RyR2 dysfunction or leak is the hallmark feature of CPVT and directly triggers arrhythmias. Despite this electrical instability, CPVT hearts are typically anatomically normal and lack pathological remodelling. Therefore, we hypothesized that introducing additional stressors, such as metabolic stress, would worsen cardiac arrhythmias and potentially trigger pathological remodelling. To test this hypothesis, metabolic stress was introduced by crossbreeding a CPVT model of CASQ2 −/− mice with the Akita mouse, a genetic model of diabetes that also lacks cardiac remodelling. We found that dysregulation of myocyte Ca 2+ handling was exacerbated in Akita‐CASQ2 −/− cells, which exhibited slower Ca 2+ transient decay kinetics and increased arrhythmogenic Ca 2+ waves. Akita‐CASQ2 −/− mice also displayed more severe arrhythmias, diastolic dysfunction, and cardiac hypertrophy, but without evidence of fibrosis, cell death, or worsened metabolic dysfunction. Finally, mitochondrial reactive oxygen species production was increased in Akita‐CASQ2 −/− cardiomyocytes, which may contribute to the more severe pathological phenotype. Overall, our results suggest that metabolic stress can aggravate dysregulated myocyte Ca 2+ handling and promote cardiac dysfunction in CPVT hearts.
No takes yet. Share an insight, caveat, or question.
Gomez et al. (2026) studied Catecholaminergic polymorphic ventricular tachycardia (CPVT) and metabolic stress/diabetes (n=121). Metabolic stress (Akita diabetes model crossbred with CASQ2-/- CPVT model) vs. Wild-type, Akita only, and CASQ2-/- only mice was evaluated on Dysregulation of myocyte Ca2+ handling and arrhythmogenic burden (p=<0.05). Metabolic stress exacerbated myocyte Ca2+ dysregulation, increasing arrhythmogenic Ca2+ waves, severe arrhythmias, diastolic dysfunction, and cardiac hypertrophy in Akita-CASQ2-/- mice compared to controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: